PFE.N
Latest Trade
55.70USDChange
1.17(+2.15%)Volume
3,965,546Today's Range
-
56.4352 Week Range
-
61.70As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 54.53 |
|---|---|
Open | 55.86 |
Volume | 3,965,546 |
3M AVG Volume | 861.17 |
Today's High | 56.43 |
Today's Low | 55.37 |
52 Week High | 61.70 |
52 Week Low | 33.36 |
Shares Out (MIL) | 5,612.87 |
Market Cap (MIL) | 306,069.60 |
Forward P/E | 12.89 |
Dividend (Yield %) | 2.93 |
Pfizer To Provide U.S. Government With Additional 10 Million Treatment Courses Of Its Covid-19 Oral Therapy
Pfizer And BionTech Receive FDA Authorization Of COVID-19 Vaccine Booster For Individuals 12 Years Of Age And Older
UK's MHRA Approves Oral COVID-19 Antiviral, Paxlovid
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
Industry
Biotechnology & Drugs
Executive Leadership
Albert Bourla
Chairman of the Board, Chief Executive Officer
Angela Hwang
Group President, Pfizer Biopharmaceuticals Group
Payal Sahni
Chief Human Resource Officer, Executive Vice President
Lidia Fonseca
Executive Vice President, Chief Technology Officer and Digital Officer
Rady A. Johnson
Executive Vice President, Chief Compliance, Quality and Risk Officer
Price To Earnings (TTM) | 16.43 |
|---|---|
Price To Sales (TTM) | 4.41 |
Price To Book (MRQ) | 4.04 |
Price To Cash Flow (TTM) | 12.80 |
Total Debt To Equity (MRQ) | 52.69 |
LT Debt To Equity (MRQ) | 47.89 |
Return on Investment (TTM) | 13.46 |
Return on Equity (TTM) | 10.59 |
Britain and Israel are overhauling their COVID-19 testing policies as governments seek to ease the burden on laboratories and struggle with tight supplies of kits amid soaring infection rates fuelled by the Omicron variant.
Pfizer Inc and Germany's BioNTech SE will develop an mRNA-based vaccine for viral infection shingles, collaborating for the third time after the success of their COVID-19 vaccine based on the same technology.
Only two cases of myocarditis were reported in Israel among 44,000 youngsters aged 12 to 15 who received a third dose of the Pfizer/BioNtech vaccine, the Health Ministry said on Wednesday.
Ireland's government agreed on Wednesday to fund the purchase of COVID-19 antiviral drugs from GlaxoSmithKline, Pfizer and Merck.
Only two cases of myocarditis were reported in Israel among 44,000 youngsters aged 12 to 15 who received a third dose of the Pfizer/BioNtech vaccine, the Health Ministry said on Wednesday.
South Korea signed an agreement to buy additional courses of Pfizer Inc's antiviral COVID-19 pill Paxlovid to cover 400,000 people, the Korea Disease Control and Prevention Agency (KDCA) said on Wednesday.
Pfizer Inc and Germany's BioNTech SE will collaborate to develop a potential mRNA-based vaccine for the prevention of viral infection shingles, the companies said on Wednesday. (Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)
A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc, Pfizer Inc and other companies over allegations their contracts with Iraq's health ministry helped fund terrorism that killed Americans during the war in Iraq.
The Biden administration doubled its order for Pfizer Inc's oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.
Brazil's Health Ministry said on Tuesday that most participants in a public hearing on vaccinating children aged 5 to 11 for COVID-19 disagreed with the need for a doctor's prescription, but it will still recommend it.
Pfizer Inc said on Tuesday the U.S. government has agreed to buy additional 10 million courses of its COVID-19 oral therapy, bringing the total amount of order by the government to 20 million courses. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli...
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday recommended shortening the interval between Pfizer-BioNTech's second COVID-19 vaccine dose and the booster shot to five months from six.
The U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday it recommends the shortening of the interval between the second dose and booster shot of Pfizer-BioNTech from 6 months to 5 months.
Japan will gear up efforts to deal with a possible surge in Omicron coronavirus cases and aim to deliver oral treatment using Pfizer Inc's drugs nationwide next month, Prime Minister Fumio Kishida said on Tuesday.
The U.S. Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children ages 12 to 15, and narrowed the interval for booster shot eligibility to five months from six.
A U.S. Centers for Disease Control and Prevention advisory panel is set to meet on Wednesday to discuss the use of a booster dose of Pfizer and BioNTech's COVID-19 vaccine for children aged 12 to 15 years, according to the agency's website https://www.cdc.gov/vaccines/acip...
The U.S. Food and Drug Administration on Monday authorized the https://www.fda.gov/media/150386/download use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children aged between 12 and 15 years. (Reporting by Ankur Banerjee and Manas Mishra in Bengaluru)
Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a spokesman for the health ministry told Reuters in an emailed statement on Monday.
Belgium will buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a spokesman for the health ministry said in an emailed statement.
Prime Minister Naftali Bennett said on Sunday that Israel would offer a fourth dose of COVID-19 vaccine to people over 60 and to medical staff as it faces a surge in Omicron variant infections.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.